VanceFowlerMDMHS
Infectious Disease • Durham, NCProfessor, Medicine, Duke University School of Medicine
Dr. Fowler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2100 Erwin Rd
Durham, NC 27705Phone+1 919-620-4467
Education & Training
Duke University HospitalFellowship, Infectious Disease, 1996 - 1999- Duke University HospitalResidency, Internal Medicine, 1993 - 1996
University of North Carolina at Chapel Hill School of MedicineClass of 1993
Certifications & Licensure
NC State Medical License 1995 - 2024- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Elected Member The American Society for Clinical Investigation, 2007
- Association of American Physicians
- Join now to see all
Clinical Trials
- Observational Study of Sepsis and Pneumonia to Develop Diagnostic Tests Start of enrollment: 2005 Dec 01
- Virulence Determinants in S Aureus Bacteremia Start of enrollment: 2004 Mar 01
- Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream Infection Start of enrollment: 2011 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 774 citationsEffect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, pla...Paul M. Ridker, Jean G. MacFadyen, Tom Thuren, Brendan M. Everett, Peter Libby
Lancet. 2017-10-21 - 417 citationsColistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant EnterobacteriaceaeDavid van Duin, Judith J. Lok, Michelle Earley, Eric Cober, Sandra S. Richter
Clinical Infectious Diseases. 2018-01-06 - 467 citationsClinical identifiers of complicated Staphylococcus aureus bacteremia.Vance G. Fowler, Maren K. Olsen, G. Ralph Corey, Christopher W. Woods, Christopher H. Cabell
Archives of Internal Medicine. 2003-09-22
Journal Articles
- Good Studies Evaluate the Disease While Great Studies Evaluate the Patient: Development and Application of a Desirability of Outcome Ranking Endpoint for Staphylococcu...Helen W Boucher, Sara E Cosgrove, G Ralph Corey, Thomas L Holland, Vance G Fowler, Clinical Infectious Diseases
Other
- Epidemiology of and risk factors for Staphylococcus aureus bacteremia in childrenFowler VG, Sexton DJ, Kaplan SL
http://www.uptodate.com/contents/epidemiology-of-and-risk-factors-for-staphylococcus-aureus-bacterem
UpToDate, Wolters Kluwer Health - 2012-10-26 - Complications of Staphylococcus aureus bacteremiaFowler VG, Sexton DJ
http://www.uptodate.com/contents/complications-of-staphylococcus-aureus-bacteremia
UpToDate, Wolters Kluwer Health - 2012-10-05 - Treatment of Staphylococcus aureus bacteremia in adultsFowler VG, Sexton DJ
http://www.uptodate.com/contents/treatment-of-staphylococcus-aureus-bacteremia-in-adults
UpToDate, Wolters Kluwer Health - 2013-03-01 - Join now to see all
Press Mentions
The Free Market Is Failing Us on AntibioticsDecember 25th, 2022- DARPA ECHO Program Testing Epigenome or DNA Changes for Tracking Exposure to Threat Agents, Weapons of Mass Destruction (WMD) on BattlefieldSeptember 30th, 2021
- Contrafect Announces Publication of Exebacase Phase 2 Study Results in the Journal of Clinical InvestigationJune 17th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
